Health ProductsType I recall

Accel-Ondansetron ODT 4 & 8 mg: Data integrity concerns with product's bioequivalence data that could lead to incorrect dosing.

· Published by Health Canada · Official notice

Details

Alert type: Health product recall
Category: Health products - Drugs
Product: Accel-Ondansetron ODT 4 & 8 mg
Issue: Health products - Product quality
What to do: Return the affected products to your local pharmacy for a replacement, and for proper disposal. If you are unsure whether your product is affected, check with your pharmacy. Consult a health care professional if you have used the affected product and you have health concerns.
Audience: General public, Healthcare, Industry
Recall class: Type I
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

BrandProduct NameMarket AuthorizationDosage FormStrengthLot
Accel-Ondansetron ODT 4 mgAccel-Ondansetron ODT 4 mgDIN 02535319Tablet (Orally Disintegrating)Ondansetron 4 mgCDX00123
Accel-Ondansetron ODT 8 mgAccel-Ondansetron ODT 8 mgDIN 02535327Tablet (Orally Disintegrating)Ondansetron 8 mgCEA00123

Issue

UPDATE: June 17, 2025 - Accel Pharma can resume sale of undistributed unit of lots CDX00123 & CEA00123 after bioequivalence test data confirm Accel-Ondansetron ODT is safe and effective to use.

Data integrity concerns with product's bioequivalence data that could lead to incorrect dosing.

Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime